Compare
Amgen vs Incyte (AMGN vs INCY)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Amgen (AMGN) returned +43.9% and Incyte (INCY) +13.2%; so far this year the figures are +40.7% and +21.1%.
Amgen is the larger company by market value, about 10.2 times the size of Incyte.
On trailing earnings, AMGN trades at 26.7 times and INCY at 63.6 times.
Revenue grew +8.2% at AMGN and +24.9% at INCY over the last year.
AMGN yields 2.16%. INCY pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| AMGN | INCY | |
|---|---|---|
| Price | $460.42 | $119.65 |
| 1-day | +0.03% | +1.39% |
| YTD | +40.67% | +21.14% |
| 1 year | +43.94% | +13.20% |
| 3 years | +76.51% | +120.07% |
| Market cap | $249.1B | $24.4B |
| P/E | 26.7 | 63.6 |
| P/S | 6.40 | 4.06 |
| P/B | 17.35 | 4.32 |
| Revenue growth | +8.20% | +24.90% |
| EPS growth | +33.30% | -68.10% |
| Gross margin % | 70.9 | 92.7 |
| Net margin % | 24.1 | 6.7 |
| ROE % | 65.4 | 7.1 |
| Debt / equity | 3.76 | 3.37 |
| FCF yield % | 3.8 | 3.1 |
| Dividend yield % | 2.16 | — |
| Beta | 0.50 | 0.44 |
| RSI (14) | 60.5 | 53.5 |
| Technical rating |